Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α subunits, increasing their affinity for the von Hippel–Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [44]
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [18]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“Cycles of rebuilding and refinement were carried out using the programs”
MethodHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Research works printed but not linked: 1
- Hubbard, S. J. & Thornton, J. M. ‘NACCESS’, Computer Program Version 2.1.1 (Department of Biochemistry and Molecular Biology, Univ. Coll. London, London, 1996)
Cited by
Items 701–770 of 770
North, M. H. (2020) · VTechWorks (Virginia Tech)
Redirecting the Cellular Waste Disposal Machinery to Target Transcription
Yu, H. H., & Sakamoto, K. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_23
Mechanisms of Substrate Recognition by the Cul3-based E3 Ligase
Rebola, K. G. D. O. (2021) · PDXScholar (Portland State University) · doi:10.15760/etd.7721
(2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm896
Angiogenesis in Liver Cancer: General Aspects and Cellular Sources of Normal Angiogenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_187
Chiang, C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737836027.793574330
Li, Z., Zhao, H., & Wan, C. (2021) · Wiley eBooks · doi:10.1002/9783527343430.ch6
The Role of the Ubiquitin–Proteasome Pathway in the Regulation of the Cellular Hypoxia Response
Nakayama, K., & Ronai, Z. A. (2006) · Wiley eBooks · doi:10.1002/9783527620227.ch6
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703813
Heavy Metal Meets Protein Homeostasis: Emerging Roles of F‐Box Proteins?
Crawford, C. E. W., & Burslem, G. M. (2025) · BioEssays · doi:10.1002/bies.202500035
“The authors emphasis of hydroxylation [5] within this context is, therefore, an expansion on well-known regulatory processes dictating how PTMs allow FBP-target protein interactions to remain sensitive to environmental perturbations.”
VEGF/VEGFR: A Novel Therapy Target in Cancer
Wanode, D. M., Nandurkar, D., Palekar, R., Bhendarkar, K. P., & Khedekar, P. B. (2025) · Current Cancer Therapy Reviews · doi:10.2174/0115733947341681241209082508
APP ubiquitination by VHL protein is essential for MVB sorting and lysosomal degradation
Shan, C., Cong, R., Xu, X., Li, Y., Tian, Y., Cao, W., Zhao, W., Miao, L., Teng, J., Huang, N., et al. (2025) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaf033
“VHL is the substrate recognition subunit of the E3 ligase—the VCB complex, which recruits Elongin B, Elongin C, and Cullin-2 to substrates (Stebbins et al., 1999 ; Hon et al., 2002 ).”
PROTACs as New Tools to Study Platelet Function
Trory, J. S., May, C., & Hers, I. (2025) · Springer eBooks · doi:10.1007/978-3-031-96344-5_27
Hypoxic gene regulation and high-throughput genetic mapping
Baird, N. A. (2008) · Scholars' Bank (University of Oregon)
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703795
Joo, H.-Y., Jung, J. K., Kim, M.-Y., Woo, S. R., Jeong, J. M., Park, E.-R., Kim, Y.-M., Park, J., Kim, J., Yun, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24225237
Joo, H.-Y., Jung, J. K., Kim, M.-Y., Woo, S. R., Jeong, J. M., Park, E.-R., Kim, Y.-M., Park, J., Kim, J., Yun, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26621263
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703804
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703810
Joo, H.-Y., Jung, J. K., Kim, M.-Y., Woo, S. R., Jeong, J. M., Park, E.-R., Kim, Y.-M., Park, J., Kim, J., Yun, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24225253
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703798
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703807
Ma, X., Tan, Z., Zhang, Q., Ma, K., Xiao, J., Wang, X., Wang, Y., Zhong, M., Wang, Y., Li, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19703801
Protacs Targeting ERα in the Effective Management of Endocrinal Resistance Breast Cancer
Singh, A., Khan, R., Erachampatt, N. A., Bhatia, N., Monga, V., & Thareja, S. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70176 · Cited by 2
“Identification of this peptide originates from hypoxia‐inducible factor 1 α subunit (HIF1α), which could bind to E3 ligase VHL, additionally create cell‐penetrating PROTACs molecules capable of degrading a range of POIs [32, 33].”
Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small MoleculesPreprint
Fouad, M. A., Parry, C. S., Miller, S. A., Malhotra, S., Doyle, G. A. R., Shimabenga, E., Nurilloeva, M., Bondarenko, E., Andrianov, G. V., Childers, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.02.697373
Avinery, L., Regev, D., Khamaisi, H., Gopas, J., & Mahajna, J. A. (2026) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2025.106240
The hypoxia signaling pathway in the skeleton
Schipani, E., Sabini, E., & Giaccia, A. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00005-0
Guerrab, A. E. (2011) · theses.fr (ABES) · doi:10.70675/0680d6aez5ddfz48efzabe9zf58f93e15842
de Becdelièvre, A. (2011) · theses.fr (ABES) · doi:10.70675/526f4178zb1f6z4af1z99c6z46bbfdf31b99 · Cited by 2
Role of iron regulatory proteins in the regulation of iron metabolism by nitric oxide
Stys, A. (2011) · theses.fr (ABES) · doi:10.70675/e4192fa6z4401z465fzbe01zd45118568a2f
Perrin‐Terrin, A. (2018) · theses.fr (ABES) · doi:10.70675/e19e922bz4ab1z4df2z8e00z839db7c46630
JMJD6 participe au maintien de l'intégrité de l'ADN ribosomique en réponse au dommage à l'ADN
Fages, J. (2020) · theses.fr (ABES) · doi:10.70675/315c9c90z557ez4c88za9cfz4f71122f0f4f
The multidimensional biology of SKP2: mechanisms, pathologies, and emerging therapeutic frontiers
Hou, T., Hua, X., Yan, P., Ni, W., Wang, J., Inuzuka, H., Simon, D. K., & Wei, W. (2026) · Acta Materia Medica · doi:10.15212/amm-2025-0094
Tewari, A., Pawar, A. B., & Roy, S. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100372 · Cited by 1
A Mechanistic Model of the HIF-1/HIF-2 Switch Regulating Hypoxia-Induced Cancer Stemness
Zhan, H., Wang, P., & Liu, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114697
“In the model, oxygen sensing is governed by the oxygen-dependent hydroxylase activity of PHDs [10].”
Yang, Q., Ding, H., Chen, L., Sun, S., Chen, C., Ren, M., Huang, F., Sun, Y., Zhang, J., Zhang, W., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03853-2
BindingDB (2020) · Discovery Research Portal (University of Dundee) · doi:10.7270/q2639scc
Programmable Nanobody‐Targeting Chimeras Enable Intracellular Viral Protein Degradation
Pan, M. Y.-C., Lee, T.-H., Peng, T., Wu, E. Y.-H., Chiu, Y., Chiu, C.-C., Nguyễn, H. V., Pao, Y.-S., Chao, M., Lee, R. K., et al. (2026) · Advanced Science · doi:10.1002/advs.76687
Sefa, S. M., Sarkar, J., Robin, A. H. K., & Uddin, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0348861
Liu, P., Chen, Q., Zhou, Z., Xu, Y., & Li, J. (2026) · Advanced Science · doi:10.1002/advs.77089
Recent advances in etiology and treatment of von Hippel-Lindau Disease (VHLD)
Pirestani, S., Nicolas, É., Broadrup, R. L., Clapper, M. L., & Golemis, E. A. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10370-x
DIPTAR: A synthetic biology platform for functional interrogation of protein degradationPreprint
Exconde, P. M., Yoo, W., Kulkarni, M., Mahale, A. B., Myers, B. E., Patio, R. C., Bourne, C. M., Discher, B. M., & Taabazuing, C. Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.26.747229
Zhao, Y., Ning, F., Wu, M., Zhang, J., Yi, M., & Zhang, C. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.181596
Single Amino Acid Disease Mutations Act as Genetic Glues to Drive Neo-substrate DegradationPreprint
Wang, B., Yeh, C.-W., Lin, H.-M., Shi, H., Mao, H., Chen, S.-C., Yeh, K., Yu, C.-H., Zheng, N., & Yen, H.-C. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.17.752235
BindingDB Entry 50010808: Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases.
BindingDB (2021) · UC San Diego · doi:10.7270/q2qn6bbk
BindingDB (2020) · UC San Diego · doi:10.7270/q2hx1gb7
BindingDB (2016) · UC San Diego · doi:10.7270/q2hd7xdm
BindingDB Entry 50030611: 2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
BindingDB (2010) · UC San Diego · doi:10.7270/q24f1qsq
BindingDB Entry 50040848: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
BindingDB (2013) · UC San Diego · doi:10.7270/q26d5v4n
BindingDB (2025) · UC San Diego · doi:10.7270/q23b64qb
BindingDB Entry 50018681: A comprehensive review of BET-targeting PROTACs for cancer therapy.
BindingDB (2024) · UC San Diego · doi:10.7270/q2930zdd
BindingDB (2024) · UC San Diego · doi:10.7270/q2x352pq
BindingDB (2020) · UC San Diego · doi:10.7270/q2736tj6
BindingDB (2022) · UC San Diego · doi:10.7270/q2280c7p
BindingDB (2024) · UC San Diego · doi:10.7270/q2pv6qt5
The Dual Role of HIF Hydroxylase PHD3 in Cancer Cell Survival
Rantanen, K. (2012) · UTUPub (University of Turku)
(2005) · PubMed · Cited by 72
Metadata
- Authors
- Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Jones, E. Yvonne
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6892
- Pages
- 975-978
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2167786713
- Cited by
- 751
- References
- 31
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 37 · 2021: 35 · 2020: 43 · 2019: 19 · 2018: 24 · 2017: 23 · 2016: 28 · 2015: 24 · 2014: 20 · 2013: 23 · 2012: 26
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, von Hippel-Lindau protein, E3 ubiquitin ligase, hypoxia, oxygen sensing, protein-protein binding, crystal structure, hydrogen bonding, ubiquitination, proteasomal degradation, transcriptional regulation
- MeSH terms
- Elongin, Amino Acid Sequence, Hypoxia, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Kinetics, Ligases, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Structure-Activity Relationship, Substrate Specificity, Transcription Factors, Sequence Alignment, Crystallography, X-Ray, Surface Plasmon Resonance, Amino Acid Motifs, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.